Office of Infectious Diseases Regulatory Science Activities

2019 Public Workshops

• Development of Antibacterial Drugs for the Treatment of Nontuberculous Mycobacterial Disease (April 8, 2019)

2018 Public Workshops

• Development of Inhaled Antibacterial Drugs for Cystic Fibrosis and Non-Cystic Fibrosis Bronchiectasis (June 27, 2108)
• Development of Non-Traditional Therapies for Bacterial Infections (August 21, 2018)

2017 Public Workshops

• Current State and Further Development of Animal Models of Serious Infections Caused by Acinetobacter baumannii and Pseudomonas aeruginosa (March 1, 2017) 
• Development of New Tuberculosis Drug Regimens-Scientific and Clinical Design Considerations (July 19, 2017)

2016 Public Workshops

• Clinical Trial Design Considerations for Malaria Drug Development (June 30, 2016)
• Facilitating Antibacterial Drug Development for Patients with Unmet Need and Developing Antibacterial Drugs that Target a Single Species (July 18 and 19, 2016)
• Anti-infective Drug Development in Neonates (September 15, 2016)
• Coordinated Development of Antimicrobial Drugs and Antimicrobial Susceptibility Test Devices (September 29, 2016)